Altered expression of KLF4\#945; promotes cell cycle progression and is associated with worse prognosis in patients with pancreatic ductal adenocarcinoma

被引:0
|
作者
Wei, Daoyan [1 ]
Kanai, Masashi [1 ]
Le, Richard [1 ]
Jia, Zhiliang [1 ]
Wang, Huamin [1 ]
Evans, Douglas [1 ]
Xie, Keping [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
617
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Expression of MAP4K4 is associated with worse prognosis in patients with pancreatic ductal adenocarcinoma
    Liang, J. J.
    Wang, H.
    Rashid, A.
    Wu, T-T
    Cleary, K. R.
    Hamilton, S. R.
    Evans, D. B.
    Hwang, R. F.
    Gomez, H. F.
    Tan, T. H.
    Zhou, G. S.
    Abbruzzese, J. L.
    Wang, H.
    MODERN PATHOLOGY, 2007, 20 : 286A - 286A
  • [2] Expression of MAP4K4 is associated with worse prognosis in patients with pancreatic ductal adenocarcinoma
    Liang, J. J.
    Wang, H.
    Rashid, A.
    Wu, T-T
    Cleary, K. R.
    Hamilton, S. R.
    Evans, D. B.
    Hwang, R. F.
    Gomez, H. F.
    Tan, T. H.
    Zhou, G. S.
    Abbruzzese, J. L.
    Wang, H.
    LABORATORY INVESTIGATION, 2007, 87 : 286A - 286A
  • [3] Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
    Liang, John J.
    Wang, Hua
    Rashid, Asif
    Tan, Tse-Hua
    Hwang, Rosa F.
    Hamilton, Stanley R.
    Abbruzzese, James L.
    Evans, Douglas B.
    Wang, Huamin
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7043 - 7049
  • [4] KLF4α Up-regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients With Pancreatic Cancer
    Wei, Daoyan
    Wang, Liwei
    Kanai, Masashi
    Jia, Zhiliang
    Le, Xiangdong
    Li, Qiang
    Wang, Huamin
    Xie, Keping
    GASTROENTEROLOGY, 2010, 139 (06) : 2135 - 2145
  • [5] Loss of Phosphomannose Isomerase Expression Associated with Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Alipour, Zahra
    Agostini-Vulaj, Diana
    Findeis-Hosey, Jennifer
    Drage, Michael
    Liu, Lei
    Zhou, Zhongren
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1631 - 1631
  • [6] Loss of Phosphomannose Isomerase Expression Associated with Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Alipour, Zahra
    Agostini-Vulaj, Diana
    Findeis-Hosey, Jennifer
    Drage, Michael
    Liu, Lei
    Zhou, Zhongren
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1631 - 1631
  • [7] SMAD4 Genetic Alterations Predict a Worse Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Singh, Puneet
    Srinivasan, Radhika
    Wig, Jai Dev
    PANCREAS, 2012, 41 (04) : 541 - 546
  • [8] High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
    Li, He
    Li, Xiaocheng
    Lin, Huapeng
    Gong, Jianping
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 822 - 832
  • [9] Adherens Junction Pathway Genetic Alterations Are Associated with Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Geffner, Adam D.
    Yu, Allen T.
    Li, Judy
    Hiotis, Spiros
    Gunasekaran, Ganesh
    Correa, Camilo
    Sarpel, Umut
    Cohen, Noah A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S160 - S160
  • [10] KRAS Mutations in Codon 12 or 13 Are Associated With Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Sinn, Bruno V.
    Striefler, Jana K.
    Rudl, Marc A.
    Lehmann, Annika
    Bahra, Marcus
    Denkert, Carsten
    Sinn, Marianne
    Stieler, Jens
    Klauschen, Frederick
    Budczies, Jan
    Weichert, Wilko
    Stenzinger, Albrecht
    Kamphues, Carsten
    Dietel, Manfred
    Riess, Hanno
    PANCREAS, 2014, 43 (04) : 578 - 583